Michelle Carpenter Email & Phone Number

Michelle Carpenter Work

• 2026 -now Chief Development Officer (Vega) @ Incyte Therapeutics
• 2014 -now Adjunct Professor @ UCSC Silicon Valley Extension
• 2020 -2026 Chief Development Officer @ Star Therapeutics
• 2013 -2026 President @ RPSpharma
• 2017 -2020 Vice President Regulatory Affairs and Project Management @ True North (acquired by Bioverativ and then Sanofi)
• 2014 -2017 Vice President, Regulatory Affairs and Project Management @ Afferent Pharmaceuticals (acquired by Merck)
• 2011 -2013 SVP, Regulatory Affairs and Clinical Development @ Acucela Inc.
• 2008 -2011 Executive Director, Regulatory Affairs @ Dow Pharmaceuticals, a subsidiary of Valeant
• 2008 -2008 V.P., Regulatory and Quality Affairs @ Oculus Innovative Sciences
• 2002 -2008 VP Regulatory and Clinical Affairs and Chief Compliance Officer @ Dey Labs, a subsidiary of KGgaA (now Mylan)
• 1995 -2002 VP, Regulatory Affairs and Project Management @ Santen, Inc.
• 1992 -1997 Manager @ InSite Vision, Inc.